Genkyotex competitorsClear all

Genkyotex's top competitors include QGel, ReViral, CG Oncology and Wren Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Genkyotex
Genkyotex
Genkyotex develops innovative drugs to block the NOX enzymes that produce oxygen radicals.
QGel
QGel
QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics.
ReViral
ReViral
ReViral is a biotechnology company developing drugs to treat RSV infections.
CG Oncology
CG Oncology
CG Oncology (formerly Cold Genesys) is a clinical-stage biopharmaceutical company focused on the research, acquisition, and development of novel immunotherapies.
Wren Therapeutics
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company, which is focused on drug discovery and development for protein misfolding diseases.
Founding Date
Founding Date
2006
Founding Date
2009
Founding Date
2011
Founding Date
2010
Founding Date
2016
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Plan-les-Ouates, CH HQ
Archamps, FR
Locations
Lausanne, CH HQ
Locations
Stevenage, GB HQ
Durham, US
Locations
Irvine, US HQ
Locations
Cambridge, GB HQ
Lund, SE
Cambridge, GB
Cambridge, US
Employees
Employees
109% decrease
Employees
147% decrease
Employees
25
Employees
254% increase
Employees
428% increase
Twitter followers
Twitter followers
N/A
Twitter followers
134
Twitter followers
222
Twitter followers
116
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
0.5
Average likes per tweet (last 30 days)
0.2
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
70%
Percentage of tweets with engagement (last 30 days)
66.67%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
415529
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
229738
Alexa Website Rank
561264

Funding

Latest funding round
Latest funding round
$ 21m (over 6 years ago)
Latest funding round
$ 12m (almost 5 years ago)
Latest funding round
$ 44m (about 1 year ago)
Latest funding round
$ 47m (9 months ago)
Latest funding round
$ 23.3m (over 2 years ago)
Total funding raised
Total funding raised
$ 72.8m
Total funding raised
$ 12m
Total funding raised
$ 121m
Total funding raised
$ 92.6m
Total funding raised
$ 23.3m
For sources of this data, please see the company profile

View company profiles

QGel
HQ
Lausanne, CH
Employees
14↓ 7% decrease

QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics.

View company
ReViral
HQ
Stevenage, GB
Employees
25

ReViral is a biotechnology company developing drugs to treat RSV infections.

View company
CG Oncology
HQ
Irvine, US
Employees
25↑ 4% increase

CG Oncology (formerly Cold Genesys) is a clinical-stage biopharmaceutical company focused on the research, acquisition, and development of novel immunotherapies.

View company
Wren Therapeutics
HQ
Cambridge, GB
Employees
42↑ 8% increase

Wren Therapeutics is a biopharmaceutical company, which is focused on drug discovery and development for protein misfolding diseases.

View company